Literature DB >> 8731629

Diagnosis of asthma and chronic obstructive pulmonary disease in general practice.

C P Van Schayck1.   

Abstract

There may be an overlap between the clinical pictures of asthma and chronic obstructive pulmonary disease which hampers a clear distinction between the two diseases. Most symptoms presented by patients do not clearly belong exclusively to either asthma or chronic obstructive pulmonary disease. By the nature of their discipline and training, general practitioners focus mainly on symptoms presented, which do not give a decisive answer in the differential diagnosis between the two diseases. Therefore, general practitioners must rely on objective parameters, such as determining the presence and degree of reversibility of airway obstruction, diurnal peak flow variability, bronchial hyper-responsiveness and allergy. This paper puts forward a pragmatic, primary care definition of asthma and chronic obstructive pulmonary disease.

Entities:  

Mesh:

Year:  1996        PMID: 8731629      PMCID: PMC1239583     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  15 in total

1.  The accuracy of portable peak flow meters.

Authors:  M R Miller; S A Dickinson; D J Hitchings
Journal:  Thorax       Date:  1992-11       Impact factor: 9.139

2.  Accuracy, precision and linearity of the portable flow-volume meter Microspiro HI-298.

Authors:  E Dompeling; C P van Schayck; H Folgering; H J van den Hoogen; C van Weel
Journal:  Eur Respir J       Date:  1991-05       Impact factor: 16.671

3.  The relationship of nonspecific bronchial responsiveness to respiratory symptoms in a random population sample.

Authors:  B Rijcken; J P Schouten; S T Weiss; F E Speizer; R van der Lende
Journal:  Am Rev Respir Dis       Date:  1987-07

4.  Screening for childhood asthma using an exercise test.

Authors:  A Jones; M Bowen
Journal:  Br J Gen Pract       Date:  1994-03       Impact factor: 5.386

Review 5.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.

Authors:  P H Quanjer; G J Tammeling; J E Cotes; O F Pedersen; R Peslin; J C Yernault
Journal:  Eur Respir J Suppl       Date:  1993-03

6.  Evaluation of the suitability of weekly peak expiratory flow rate measurements in monitoring annual decline in lung function among patients with asthma and chronic bronchitis.

Authors:  P R Tirimanna; J J Den Otter; C P Van Schayck; C L Van Herwaarden; H Folgering; C Van Weel
Journal:  Br J Gen Pract       Date:  1996-01       Impact factor: 5.386

7.  Does bronchial hyperresponsiveness precede or follow airway obstruction in asthma or COPD?

Authors:  C P van Schayck; E Dompeling; J Molema; H Folgering; P M van Grunsven; C van Weel
Journal:  Neth J Med       Date:  1994-10       Impact factor: 1.422

8.  A "splitting" look at chronic nonspecific lung disease (CNSLD): common features but diverse pathogenesis.

Authors:  P A Vermeire; N B Pride
Journal:  Eur Respir J       Date:  1991-04       Impact factor: 16.671

9.  Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction.

Authors:  F W Dekker; A C Schrier; P J Sterk; J H Dijkman
Journal:  Thorax       Date:  1992-03       Impact factor: 9.139

10.  Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group.

Authors:  P L Brand; P H Quanjer; D S Postma; H A Kerstjens; G H Koëter; P N Dekhuijzen; H J Sluiter
Journal:  Thorax       Date:  1992-06       Impact factor: 9.139

View more
  7 in total

Review 1.  Long acting beta(2) agonists and theophylline in stable chronic obstructive pulmonary disease.

Authors:  M Cazzola; C F Donner; M G Matera
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

2.  Testing bronchial hyper-responsiveness: provocation or peak expiratory flow variability?

Authors:  J J den Otter; G M Reijnen; W J van den Bosch; C P van Schayck; J Molema; C van Weel
Journal:  Br J Gen Pract       Date:  1997-08       Impact factor: 5.386

3.  Prevalence of obstructive lung disease in a general population sample: the NICECOPD study.

Authors:  Eoin Murtagh; Liam Heaney; Jenny Gingles; Richard Shepherd; Frank Kee; Chris Patterson; Joe MacMahon
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

4.  The Nottingham Health Profile: score distribution, internal consistency and validity in asthma and COPD patients.

Authors:  M P Jans; F G Schellevis; J T van Eijk
Journal:  Qual Life Res       Date:  1999-09       Impact factor: 4.147

5.  Screening older patients for obstructive airways disease in a semi-rural practice.

Authors:  J A Dickinson; M Meaker; M Searle; G Ratcliffe
Journal:  Thorax       Date:  1999-06       Impact factor: 9.139

6.  The role of coping resources and coping style in quality of life of patients with asthma or COPD.

Authors:  A E Hesselink; B W J H Penninx; M A G Schlösser; H A H Wijnhoven; D A W M van der Windt; D M W Kriegsman; J Th M van Eijk
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

7.  The added value of C-reactive protein to clinical signs and symptoms in patients with obstructive airway disease: results of a diagnostic study in primary care.

Authors:  Antonius Schneider; Geert-Jan Dinant; Inko Maag; Lutz Gantner; Joachim Franz Meyer; Joachim Szecsenyi
Journal:  BMC Fam Pract       Date:  2006-05-02       Impact factor: 2.497

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.